A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

UC San Diego Moores Cancer Center, La Jolla, California, United States

Saddleback Memorial Medical Center, Laguna Hills, California, United States

Hoag Memorial Hospital, Newport Beach, California, United States

University of California Los Angeles (UCLA) - Cancer Care - Santa Monica, Santa Monica, California, United States

Georgetown University, Washington D.C., District of Columbia, United States

AdventHealth Cancer Institute, Orlando, Florida, United States

Winship Cancer Institute of Emory University, Atlanta, Georgia, United States

University of Illinois Cancer Center, Chicago, Illinois, United States

Kansas City VA Medical Center, Kansas City, Kansas, United States

Walter Reed National Military Medical Center, Bethesda, Maryland, United States

Christus Health - Christus St. Vincent Regional Medical Center, Santa Fe, New Mexico, United States

Stony Brook Univ Cancer Ctr, Stony Brook, New York, United States

East Carolina University, Greenville, North Carolina, United States

Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Renovatio Clinical - El Paso, El Paso, Texas, United States

Baylor College of Medicine, Houston, Texas, United States

Renovatio Clinical, The Woodlands, Texas, United States

Auxilio Mutuo Cancer Center, San Juan, Puerto Rico